Published in Malar J on January 13, 2010
A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis (2012) 5.24
Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev (2013) 2.36
Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis (2010) 2.24
Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature. Malar J (2012) 1.72
Malaria in selected non-Amazonian countries of Latin America. Acta Trop (2011) 1.53
Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia. PLoS One (2014) 1.39
Resistance to chloroquine unhinges vivax malaria therapeutics. Antimicrob Agents Chemother (2011) 1.34
Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One (2012) 1.29
Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia. PLoS Negl Trop Dis (2011) 1.23
Defying malaria: Fathoming severe Plasmodium vivax disease. Nat Med (2011) 1.18
Plasmodium vivax treatments: what are we looking for? Curr Opin Infect Dis (2011) 1.16
Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? Am J Trop Med Hyg (2014) 1.12
Augmented plasma microparticles during acute Plasmodium vivax infection. Malar J (2010) 1.09
Cytokine balance in human malaria: does Plasmodium vivax elicit more inflammatory responses than Plasmodium falciparum? PLoS One (2012) 1.06
Severe disease in children hospitalized with a diagnosis of Plasmodium vivax in south-eastern Pakistan. Malar J (2012) 1.05
Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infect Immun (2012) 1.04
Increased interleukin-10 and interferon-γ levels in Plasmodium vivax malaria suggest a reciprocal regulation which is not altered by IL-10 gene promoter polymorphism. Malar J (2011) 1.03
Networking the host immune response in Plasmodium vivax malaria. Malar J (2013) 1.02
Clinico-laboratory profile of severe Plasmodium vivax malaria in a tertiary care centre in Kolkata. Trop Parasitol (2013) 1.02
Thrombocytopenia in Plasmodium vivax malaria is related to platelets phagocytosis. PLoS One (2013) 1.01
Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemia. PLoS Negl Trop Dis (2013) 1.00
Neutrophil paralysis in Plasmodium vivax malaria. PLoS Negl Trop Dis (2012) 1.00
Plasmodium vivax associated severe malaria complications among children in some malaria endemic areas of Ethiopia. BMC Public Health (2013) 1.00
Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. PLoS One (2011) 1.00
Study of C reactive protein as a prognostic marker in malaria from Eastern India. Adv Biomed Res (2012) 1.00
Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria. PLoS Pathog (2015) 0.98
Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia. BMC Med (2014) 0.98
Clinical profile of concurrent dengue fever and Plasmodium vivax malaria in the Brazilian Amazon: case series of 11 hospitalized patients. Am J Trop Med Hyg (2012) 0.97
Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier. PLoS Pathog (2014) 0.97
Host immune response in returning travellers infected with malaria. Malar J (2012) 0.96
Malaria-related anaemia: a Latin American perspective. Mem Inst Oswaldo Cruz (2011) 0.95
Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. PLoS Negl Trop Dis (2010) 0.94
Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases. Front Pharmacol (2012) 0.94
Malaria-induced splenic infarction. Am J Trop Med Hyg (2014) 0.93
Severe morbidity and mortality risk from malaria in the United States, 1985-2011. Open Forum Infect Dis (2014) 0.92
The CD14+CD16+ inflammatory monocyte subset displays increased mitochondrial activity and effector function during acute Plasmodium vivax malaria. PLoS Pathog (2014) 0.92
Serious and fatal illness associated with falciparum and vivax malaria among patients admitted to hospital at West Sumba in eastern Indonesia. Am J Trop Med Hyg (2012) 0.92
A descriptive study of 16 severe Plasmodium vivax cases from three municipalities of Colombia between 2009 and 2013. Malar J (2014) 0.91
Anti-inflammatory cytokines predominate in acute human Plasmodium knowlesi infections. PLoS One (2011) 0.91
Molecular epidemiology of Plasmodium vivax anti-folate resistance in India. Malar J (2011) 0.91
Suppression of erythroid development in vitro by Plasmodium vivax. Malar J (2012) 0.89
Antigenic repertoire of Plasmodium vivax transmission-blocking vaccine candidates from the Indian subcontinent. Malar J (2011) 0.88
Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon. Am J Trop Med Hyg (2013) 0.87
Potential immune mechanisms associated with anemia in Plasmodium vivax malaria: a puzzling question. Infect Immun (2014) 0.86
Maternal clinical findings in malaria in pregnancy in a region of northwestern Colombia. Am J Trop Med Hyg (2013) 0.85
Parasite virulence, co-infections and cytokine balance in malaria. Pathog Glob Health (2014) 0.84
Alterations in cytokines and haematological parameters during the acute and convalescent phases of Plasmodium falciparum and Plasmodium vivax infections. Mem Inst Oswaldo Cruz (2014) 0.84
Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil. Malar J (2014) 0.84
Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production. J Infect Dis (2015) 0.84
Acute pancreatitis, ascites, and acute renal failure in Plasmodium vivax malaria infection, a rare complication. Trop Parasitol (2015) 0.83
Plasmodium vivax lineages: geographical distribution, tandem repeat polymorphism, and phylogenetic relationship. Malar J (2011) 0.83
Acalculous cholecystitis occurring in the context of Plasmodium malariae infection: a case report. J Med Case Rep (2013) 0.83
Unravelling the patterns of host immune responses in Plasmodium vivax malaria and dengue co-infection. Malar J (2015) 0.83
Tumor necrosis factor -α, interleukin-10, intercellular and vascular adhesion molecules are possible biomarkers of disease severity in complicated Plasmodium vivax isolates from Pakistan. PLoS One (2013) 0.82
Elimination therapy for the endemic malarias. Curr Infect Dis Rep (2012) 0.82
Molecular analysis of reticulocyte binding protein-2 gene in Plasmodium vivax isolates from India. BMC Microbiol (2012) 0.82
Neutral polymorphisms in putative housekeeping genes and tandem repeats unravels the population genetics and evolutionary history of Plasmodium vivax in India. PLoS Negl Trop Dis (2013) 0.81
The robust and modulated biomarker network elicited by the Plasmodium vivax infection is mainly mediated by the IL-6/IL-10 axis and is associated with the parasite load. J Immunol Res (2014) 0.81
DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malaria. Malar J (2014) 0.81
Analysis of lymphocytes in patients with Plasmodium vivax malaria and its relation to the annexin-A1 and IL-10. Malar J (2013) 0.80
Plasma circulating nucleic acids levels increase according to the morbidity of Plasmodium vivax malaria. PLoS One (2011) 0.80
IL10A genotypic association with decreased IL-10 circulating levels in malaria infected individuals from endemic area of the Brazilian Amazon. Malar J (2015) 0.79
Phenotypic profiling of CD8(+) T cells during Plasmodium vivax blood-stage infection. BMC Infect Dis (2015) 0.79
Renal cortical necrosis: A rare complication of Plasmodium vivax malaria. Indian J Nephrol (2014) 0.78
Malaria caused by Plasmodium vivax complicated by acalculous cholecystitis. Am J Trop Med Hyg (2011) 0.78
Immunoregulation in human malaria: the challenge of understanding asymptomatic infection. Mem Inst Oswaldo Cruz (2015) 0.77
Complicated malaria symptoms associated with Plasmodium vivax among patients visiting health facilities in Mendi town, Northwest Ethiopia. BMC Infect Dis (2016) 0.77
Genetic variability in platelet integrin α2β1 density: possible contributor to Plasmodium vivax-induced severe thrombocytopenia. Am J Trop Med Hyg (2012) 0.77
A case of vivax malaria complicated by adult respiratory distress syndrome and successful management with extracorporeal membrane oxygenation. Korean J Parasitol (2013) 0.77
Biomarkers of mercury exposure in the Amazon. Biomed Res Int (2014) 0.77
Retinopathy of vivax malaria in adults and its relation with severity parameters. Pathog Glob Health (2016) 0.76
Associations between systemic inflammation, mycobacterial loads in sputum and radiological improvement after treatment initiation in pulmonary TB patients from Brazil: a prospective cohort study. BMC Infect Dis (2016) 0.76
Polymorphisms in Plasmodium vivax Circumsporozoite Protein (CSP) Influence Parasite Burden and Cytokine Balance in a Pre-Amazon Endemic Area from Brazil. PLoS Negl Trop Dis (2016) 0.76
An unusual case of Plasmodium vivax malaria monoinfection associated with crescentic glomerulonephritis: a need for vigilance. Parasitol Res (2012) 0.76
Fatal cerebral malaria: a venous efflux problem. Front Cell Infect Microbiol (2014) 0.76
Concurrent Inflammation Augments Antimalarial Drugs-Induced Liver Injury in Rats. Adv Pharm Bull (2016) 0.75
Incidence of Jaundice in Plasmodium vivax Malaria: A Prospective Study in Moodabidri, South India. Malays J Med Sci (2014) 0.75
Frequency of TNFA, INFG, and IL10 Gene Polymorphisms and Their Association with Malaria Vivax and Genomic Ancestry. Mediators Inflamm (2016) 0.75
Retinal Hemorrhages in Severe Non-cerebral Plasmodium vivax Malaria in an Adult. J Clin Diagn Res (2015) 0.75
Associations between hepcidin and immune response in individuals with hyperbilirubinaemia and severe malaria due to Plasmodium vivax infection. Malar J (2015) 0.75
Deletion of C-reactive protein ameliorates experimental cerebral malaria? Trans R Soc Trop Med Hyg (2014) 0.75
Acute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor Function. PLoS Pathog (2016) 0.75
Unusual presentation of vivax malaria with anaemia, thrombocytopenia, jaundice, renal disturbance, and melena: a report from malang, a nonendemic area in indonesia. Case Rep Infect Dis (2013) 0.75
TOLLIP gene variant is associated with Plasmodium vivax malaria in the Brazilian Amazon. Malar J (2017) 0.75
On the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease. Malar J (2017) 0.75
Increased CD11b and Hypoxia-Inducible Factors-1alpha Expressions in the Lung Tissue and Surfactant Protein-D Levels in Serum Are Related with Acute Lung Injury in Severe Malaria of C57BL/6 Mice. Iran J Parasitol (2017) 0.75
Severe Malaria Associated with Plasmodium falciparum and P. vivax among Children in Pawe Hospital, Northwest Ethiopia. Malar Res Treat (2016) 0.75
Immune response pattern in recurrent Plasmodium vivax malaria. Malar J (2016) 0.75
Thrombocytopenia in Plasmodium vivax Malaria: How Significant? J Trop Med (2014) 0.75
What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates? Front Immunol (2017) 0.75
Diagnosis and Treatment of Plasmodium vivax Malaria. Am J Trop Med Hyg (2016) 0.75
Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg (2000) 22.12
High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol (1993) 17.06
Vivax malaria: neglected and not benign. Am J Trop Med Hyg (2007) 10.16
Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med (2008) 6.61
Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med (2008) 5.29
The pathophysiology of vivax malaria. Trends Parasitol (2009) 4.57
High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg (2002) 4.35
Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg (2007) 3.07
Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis (2007) 3.02
Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clin Infect Dis (2008) 2.80
The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis (1999) 2.49
Human malarial disease: a consequence of inflammatory cytokine release. Malar J (2006) 2.36
Detection and identification of the four malaria parasite species infecting humans by PCR amplification. Methods Mol Biol (1996) 2.14
Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg (2002) 2.08
Acute renal failure in Plasmodium vivax malaria. J Assoc Physicians India (2003) 2.02
Renal failure in malaria. J Vector Borne Dis (2008) 1.91
Occurrence of thrombocytopenia in Plasmodium vivax malaria. Clin Infect Dis (2005) 1.75
Plasmodium vivax malaria presenting with severe thrombocytopenia. Braz J Infect Dis (2002) 1.73
Acute respiratory distress syndrome complicating Plasmodium vivax malaria. Crit Care Med (2001) 1.70
Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of Brazil. Am J Trop Med Hyg (2009) 1.69
Cerebral malaria owing to Plasmodium vivax: case report. Ann Trop Paediatr (2006) 1.64
Blood coagulation, inflammation, and malaria. Microcirculation (2008) 1.54
The paroxysm of Plasmodium vivax malaria. Trends Parasitol (2003) 1.41
Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Malar J (2009) 1.30
How prevalent is Plasmodium malariae in Rondônia, western Brazilian Amazon? Rev Soc Bras Med Trop (2000) 1.19
[Spatial analysis and determination of malaria control areas in the State of Rondônia]. Rev Soc Bras Med Trop (2008) 1.06
Hepatic dysfunction in a patient with Plasmodium vivax infection. MedGenMed (2005) 0.97
Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria. Afr Health Sci (2009) 0.96
[Plasmodium vivax malaria in the Brazilian Amazon: some aspects of its epidemiology, clinical spectrum and naturally induced immune responses]. Bull Soc Pathol Exot (2008) 0.91
Cytokines and clinical manifestations of malaria in adults with severe and uncomplicated disease. Int Marit Health (2005) 0.90
Sepsis due to extended-spectrum beta-lactamase-producing Aeromonas hydrophila in a pediatric patient with diarrhea and pneumonia. Clin Infect Dis (2005) 0.88
Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity. J Infect Dis (2002) 1.83
CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis (2006) 1.77
Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva. PLoS Negl Trop Dis (2007) 1.63
Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America. PLoS Negl Trop Dis (2010) 1.60
Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection. J Immunol (2009) 1.41
CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis. J Invest Dermatol (2013) 1.39
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infect Dis (2005) 1.39
Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. Eur J Immunol (2007) 1.38
Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment. J Immunol (2005) 1.37
Anti-Anopheles darlingi saliva antibodies as marker of Plasmodium vivax infection and clinical immunity in the Brazilian Amazon. Malar J (2009) 1.30
Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis. Infect Immun (2005) 1.27
IFN-beta impairs superoxide-dependent parasite killing in human macrophages: evidence for a deleterious role of SOD1 in cutaneous leishmaniasis. J Immunol (2009) 1.26
Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis. J Leukoc Biol (2008) 1.25
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas. PLoS Negl Trop Dis (2010) 1.25
Inflammatory cell infiltration and high antibody production in BALB/c mice caused by natural exposure to Lutzomyia longipalpis bites. Am J Trop Med Hyg (2005) 1.24
Antibodies against Lutzomyia longipalpis saliva in the fox Cerdocyon thous and the sylvatic cycle of Leishmania chagasi. Trans R Soc Trop Med Hyg (2006) 1.22
Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop (2005) 1.20
Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines. Eur J Immunol (2010) 1.20
Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol (2005) 1.18
Cooperation between apoptotic and viable metacyclics enhances the pathogenesis of Leishmaniasis. PLoS One (2009) 1.17
Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infect Immun (2005) 1.12
Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages. Microbes Infect (2002) 1.10
Lung granulomas from Mycobacterium tuberculosis/HIV-1 co-infected patients display decreased in situ TNF production. Pathol Res Pract (2007) 1.09
Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis. Clin Infect Dis (2003) 1.09
Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia. PLoS Negl Trop Dis (2011) 1.08
The host genetic diversity in malaria infection. J Trop Med (2012) 1.08
Frequency of infection of Lutzomyia phlebotomines with Leishmania braziliensis in a Brazilian endemic area as assessed by pinpoint capture and polymerase chain reaction. Mem Inst Oswaldo Cruz (2002) 1.06
Leishmania amazonensis infection impairs differentiation and function of human dendritic cells. J Leukoc Biol (2007) 1.05
Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infect Immun (2012) 1.04
Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice. Microbes Infect (2008) 1.03
Lutzomyia longipalpis salivary gland homogenate impairs cytokine production and costimulatory molecule expression on human monocytes and dendritic cells. Infect Immun (2004) 1.03
Seasonal patterns of viral and bacterial infections among children hospitalized with community-acquired pneumonia in a tropical region. Scand J Infect Dis (2010) 1.02
Haematophagous arthropod saliva and host defense system: a tale of tear and blood. An Acad Bras Cienc (2005) 1.02
Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice. Microbes Infect (2004) 1.02
Networking the host immune response in Plasmodium vivax malaria. Malar J (2013) 1.02
Lutzomyia longipalpis saliva triggers lipid body formation and prostaglandin E₂ production in murine macrophages. PLoS Negl Trop Dis (2010) 1.02
Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis. PLoS Negl Trop Dis (2010) 1.02
Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis. Am J Trop Med Hyg (2011) 1.01
Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. PLoS One (2011) 1.00
Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens. Clin Vaccine Immunol (2006) 1.00
Potential of KM+ lectin in immunization against Leishmania amazonensis infection. Vaccine (2006) 1.00
Metabolic adaptation to tissue iron overload confers tolerance to malaria. Cell Host Microbe (2012) 1.00
Heme impairs prostaglandin E2 and TGF-beta production by human mononuclear cells via Cu/Zn superoxide dismutase: insight into the pathogenesis of severe malaria. J Immunol (2010) 0.99
Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses. Infect Immun (2002) 0.98
The role of respiratory viral infections among children hospitalized for community-acquired pneumonia in a developing country. Pediatr Infect Dis J (2008) 0.97
Role of Toll-like receptor 9 signaling in experimental Leishmania braziliensis infection. Infect Immun (2013) 0.97
American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline. Int J Dermatol (2003) 0.97
Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection. J Immunol (2012) 0.96
Prognostic value of cytokines and chemokines in addition to the GRACE Score in non-ST-elevation acute coronary syndromes. Clin Chim Acta (2010) 0.96
The replication of human immunodeficiency virus type 1 in macrophages is enhanced after phagocytosis of apoptotic cells. J Infect Dis (2002) 0.96
Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils. J Leukoc Biol (2011) 0.95
Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection. PLoS Negl Trop Dis (2013) 0.95